Clinical Trial Update: A Pharmacokinetic Study to Assess Nevirapine [Viramune] Levels in HIV Infected Patients With Impaired Hepatic Functions [Phase 4]

View source ↗

Summary

A Phase 4 pharmacokinetic study evaluating nevirapine levels in HIV-infected patients with hepatic impairment.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Viramune (Nevirapine)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: HIV Infections, Hepatic Insufficiency | Phase 4 | Status: COMPLETED